Articles

Topic

All Analytics Antibody-drug conjugates Bioanalytics Biologics Biosimilars Biostatistics Cancer Cell culture Clinical trials Contamination Drug development Drug product Drug substance EMA FDA GMP Mabion Manufacturing Microbiology Regulatory Vaccines Veterinary biologics

The scientist conducting analysis in a laboratory.

Does Your CDMO Have An Analytical Edge?

Analytics, Biosimilars, Mabion

Innovative biologics that are expected to be approved in 2025

Innovative biologics – expected drug approvals in 2025

Antibody-drug conjugates, Biologics, Bispecific antibody, Clinical trials, EMA, FDA, Monoclonal antibody, Vaccines

biologics cdmo

Biologics CDMO Solutions for the Future of Therapeutics

Biologics, Drug development, Manufacturing

Bioprocess operation modes. Bioreactors used in pharmaceutical biotechnology.

Bioprocess operation modes and advanced bioreactor technology

Cell culture, Drug substance, Manufacturing

Ion-exchange chromatography

Ion exchange chromatography in monoclonal antibodies purification

Analytics, Manufacturing

Enhancing biotechnological research with Design of Experiments

Biostatistics

1 2 … 4 Next